Execution Risk Is What’s Slowing Healthcare Real Estate Deals
- Shane Lovelady
- Apr 7
- 2 min read
The biggest reason healthcare real estate deals are slowing right now is not demand. It is execution risk. In a disciplined market, buyers and lenders are less concerned with whether a deal looks good on paper and more focused on whether it can actually be completed without disruption.
Execution risk shows up in several ways. Tenant readiness. Construction timelines. Financing certainty. Operator capacity. Any one of these factors can introduce delays or uncertainty that make a deal harder to close.
This is why simpler deals are moving faster. A stabilized outpatient building with an established tenant base and minimal capital requirements is easier to execute than a project that depends on lease up, build out, or multiple moving parts. The fewer variables involved, the easier it is for all parties to move forward with confidence.
Lenders are especially sensitive to execution risk. In the current environment, they are prioritizing deals where timelines are clear and assumptions are realistic. Projects that require perfect conditions or aggressive projections are facing more resistance.
Operators are adjusting as well. Many are focusing on optimizing existing locations or pursuing incremental expansion rather than taking on large, complex projects. This approach reduces risk and aligns more closely with current financing conditions.
Healthcare real estate is not lacking opportunity. It is being filtered by how achievable that opportunity is. The deals that move forward are the ones that can be executed cleanly from start to finish.
As the market continues into Q2, execution risk will remain one of the main factors separating deals that close from those that stall.
If you want to evaluate how execution risk may impact a deal or development plan, let’s connect and walk through it together.
Book a call:
Subscribe to the newsletter:
Comments